Marcus M. Reidenberg

6.7k total citations
140 papers, 4.9k citations indexed

About

Marcus M. Reidenberg is a scholar working on Pediatrics, Perinatology and Child Health, Molecular Biology and Pharmacology. According to data from OpenAlex, Marcus M. Reidenberg has authored 140 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pediatrics, Perinatology and Child Health, 26 papers in Molecular Biology and 22 papers in Pharmacology. Recurrent topics in Marcus M. Reidenberg's work include Pharmaceutical studies and practices (16 papers), Pharmacogenetics and Drug Metabolism (11 papers) and Systemic Lupus Erythematosus Research (10 papers). Marcus M. Reidenberg is often cited by papers focused on Pharmaceutical studies and practices (16 papers), Pharmacogenetics and Drug Metabolism (11 papers) and Systemic Lupus Erythematosus Research (10 papers). Marcus M. Reidenberg collaborates with scholars based in United States, United Kingdom and Nigeria. Marcus M. Reidenberg's co-authors include Dennis E. Drayer, David Löwenthal, Beverly Lorenzo, Raymond Sacks, Melton B. Affrime, Howard Warner, Alan S. Nies, Raymond L. Woosley, Magnus Borga and Ingegerd Odar‐Cederlöf and has published in prestigious journals such as New England Journal of Medicine, JAMA and PEDIATRICS.

In The Last Decade

Marcus M. Reidenberg

137 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcus M. Reidenberg United States 41 1.0k 814 710 625 579 140 4.9k
Daniel L. Azarnoff United States 40 2.0k 1.9× 626 0.8× 971 1.4× 651 1.0× 266 0.5× 132 5.7k
Wayne A. Colburn United States 34 1.1k 1.1× 513 0.6× 577 0.8× 462 0.7× 182 0.3× 136 3.9k
Aziz Karim United States 37 1.2k 1.2× 456 0.6× 722 1.0× 1.2k 1.9× 497 0.9× 127 5.5k
Jérôme Biollaz Switzerland 41 1.2k 1.2× 683 0.8× 432 0.6× 451 0.7× 1.7k 3.0× 155 6.1k
Steven Schenker United States 55 1.6k 1.6× 1.4k 1.7× 1.5k 2.1× 554 0.9× 339 0.6× 172 10.2k
P. van Brummelen Netherlands 36 692 0.7× 422 0.5× 410 0.6× 365 0.6× 1.5k 2.6× 136 3.9k
Roger K. Verbeeck Belgium 36 647 0.6× 807 1.0× 1.4k 1.9× 1.2k 1.9× 246 0.4× 156 4.7k
Allen J. Sedman United States 32 603 0.6× 513 0.6× 531 0.7× 661 1.1× 251 0.4× 86 3.2k
Robert E. Vestal United States 34 825 0.8× 482 0.6× 738 1.0× 529 0.8× 784 1.4× 108 4.8k
Janice B. Schwartz United States 41 2.6k 2.5× 684 0.8× 613 0.9× 488 0.8× 1.7k 2.9× 146 7.7k

Countries citing papers authored by Marcus M. Reidenberg

Since Specialization
Citations

This map shows the geographic impact of Marcus M. Reidenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus M. Reidenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus M. Reidenberg more than expected).

Fields of papers citing papers by Marcus M. Reidenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcus M. Reidenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus M. Reidenberg. The network helps show where Marcus M. Reidenberg may publish in the future.

Co-authorship network of co-authors of Marcus M. Reidenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Marcus M. Reidenberg. A scholar is included among the top collaborators of Marcus M. Reidenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcus M. Reidenberg. Marcus M. Reidenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reidenberg, Marcus M.. (2011). Drug Discontinuation Effects Are Part of the Pharmacology of a Drug. Journal of Pharmacology and Experimental Therapeutics. 339(2). 324–328. 53 indexed citations
2.
Jung, Beth F. & Marcus M. Reidenberg. (2006). The Risk of Action by the Drug Enforcement Administration Against Physicians Prescribing Opioids for Pain. Pain Medicine. 7(4). 353–357. 15 indexed citations
3.
Reidenberg, Marcus M., et al.. (2005). The Risk of Disciplinary Action by State Medical Boards Against Physicians Prescribing Opioids. Journal of Medical Regulation. 91(2). 14–19. 2 indexed citations
4.
Reidenberg, Marcus M.. (2004). Issues in Developing the Medical Scientist, Part 3: Evaluation of Scientific Achievement (Essay by and Interview with Marcus M. Reidenberg, MD). Journal of Investigative Medicine. 52(6). 361–363. 3 indexed citations
5.
Poznak, Catherine Van, Andrew D. Seidman, Marcus M. Reidenberg, et al.. (2001). Oral Gossypol in the Treatment of Patients with Refractory Metastatic Breast Cancer: A Phase I/II Clinical Trial. Breast Cancer Research and Treatment. 66(3). 239–248. 184 indexed citations
6.
Bushunow, Peter, Marcus M. Reidenberg, John J. Wasenko, et al.. (1999). Gossypol Treatment of Recurrent Adult Malignant Gliomas. Journal of Neuro-Oncology. 43(1). 79–86. 114 indexed citations
7.
Reidenberg, Marcus M.. (1998). Decreasing publication bias. Clinical Pharmacology & Therapeutics. 63(1). 1–3. 6 indexed citations
8.
Notterman, Daniel A., et al.. (1990). Dopamine clearance in critically ill infants and children: Effect of age and organ system dysfunction. Clinical Pharmacology & Therapeutics. 48(2). 138–147. 20 indexed citations
9.
Reidenberg, Marcus M.. (1990). The history of Clinical Pharmacology & Therapeutics. Clinical Pharmacology & Therapeutics. 47. 277–279. 1 indexed citations
10.
Reidenberg, Marcus M.. (1989). Padding the curriculum vitae: Impairing the utility and integrity of the biomedical literature. Clinical Pharmacology & Therapeutics. 45(4). 337–339. 2 indexed citations
11.
Aucoin, David P., Robert L. Rubin, Mark E. Peterson, et al.. (1988). Dose‐dependent induction of anti–native dna antibodies in cats by propylthiouracil. Arthritis & Rheumatism. 31(5). 688–692. 18 indexed citations
12.
Wu, Dafang, Marcus M. Reidenberg, & Dennis E. Drayer. (1988). Determination of gossypol enantiomers in plasma after administration of racemate using high-performance liquid chromatography with precolumn chemical derivatisation. Journal of Chromatography B Biomedical Sciences and Applications. 433. 141–148. 18 indexed citations
13.
Notterman, Daniel A., et al.. (1986). Stereoselective renal tubular secretion of quinidine and quinine. Clinical Pharmacology & Therapeutics. 40(5). 511–517. 57 indexed citations
14.
Reidenberg, Marcus M. & Dennis E. Drayer. (1984). Alteration of Drug-Protein Binding in Renal Disease. Clinical Pharmacokinetics. 9(Supplement 1). 18–26. 82 indexed citations
15.
Reidenberg, Marcus M.. (1981). Environmental Factors in Renal Disease. PubMed. 5(1-2). 101–109.
16.
Reidenberg, Marcus M., M. Camacho, Jeffrey Kluger, & Dennis E. Drayer. (1980). Aging and renal clearance of procainamide and acetylprocainamide. Clinical Pharmacology & Therapeutics. 28(6). 732–735. 48 indexed citations
17.
Reidenberg, Marcus M.. (1974). Effect of Disease States on Plasma Protein Binding of Drugs. Medical Clinics of North America. 58(5). 1103–1109. 25 indexed citations
18.
Reidenberg, Marcus M., et al.. (1973). Hydralazine elimination in man. Clinical Pharmacology & Therapeutics. 14(6). 970–977. 100 indexed citations
19.
Harakal, Concetta, et al.. (1968). EFFECT OF ADRENAL MEDULLECTOMY AND TOTAL ADRENALECTOMY ON THE HEMODYNAMIC RESPONSES TO TYRAMINE. Journal of Pharmacology and Experimental Therapeutics. 160(2). 292–299. 5 indexed citations
20.
Reidenberg, Marcus M., et al.. (1963). Hemodynamic Changes in Adrenalectomized Dogs. Endocrinology. 72(6). 918–923. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel L. Azarnoff Breakdown of academic impact, for papers by Wayne A. Colburn Breakdown of academic impact, for papers by Aziz Karim Breakdown of academic impact, for papers by Jérôme Biollaz Breakdown of academic impact, for papers by Steven Schenker Breakdown of academic impact, for papers by P. van Brummelen Breakdown of academic impact, for papers by Roger K. Verbeeck Breakdown of academic impact, for papers by Allen J. Sedman Breakdown of academic impact, for papers by Robert E. Vestal Breakdown of academic impact, for papers by Janice B. Schwartz
Rankless by CCL
2026